{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T00:26:22Z","timestamp":1793406382121,"version":"4.5.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004263","name":"Foundation for Research Support of Rio Grande do Sul State","doi-asserted-by":"publisher","award":["17\/2551-0000514-7"],"award-info":[{"award-number":["17\/2551-0000514-7"]}],"id":[{"id":"10.13039\/501100004263","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018799","name":"Instituto Nacional de Pesquisas em Resist\u00eancia a Antimicrobianos","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018799","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["465718\/2014-0"],"award-info":[{"award-number":["465718\/2014-0"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.diagmicrobio.2025.116965","type":"journal-article","created":{"date-parts":[[2025,6,22]],"date-time":"2025-06-22T01:21:49Z","timestamp":1750555309000},"page":"116965","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["First report of ceftazidime-avibactam resistance in non-mutated blaKPC-3 K. pneumoniae recovered from patients with no prior treatment, in Latin America"],"prefix":"10.1016","volume":"113","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5130-9057","authenticated-orcid":false,"given":"M.P.","family":"Mott","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.K.","family":"Moreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Collar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Scalco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.B.","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Vieira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.S.","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.F.","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Barth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Caier\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10325","key":"10.1016\/j.diagmicrobio.2025.116965_bib0001","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis","volume":"399","author":"Murray","year":"2022","journal-title":"The Lancet."},{"issue":"7","key":"10.1016\/j.diagmicrobio.2025.116965_bib0002","doi-asserted-by":"crossref","first-page":"e141","DOI":"10.1093\/cid\/ciz1095","article-title":"An emerging clone, klebsiellapneumoniae carbapenemase 2\u2013Producing K. pneumoniae sequence type 16, associated with high mortality rates in a CC258-endemic setting","volume":"71","author":"Andrey","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2025.116965_bib0003","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-41903-x","article-title":"Genomic analysis and antimicrobial activity of \u03b2-lactam\/\u03b2-lactamase inhibitors and other agents against KPC-producing Klebsiella pneumoniae clinical isolates from Brazilian hospitals","volume":"13","author":"Camargo","year":"2023","journal-title":"Sci Rep."},{"issue":"6","key":"10.1016\/j.diagmicrobio.2025.116965_bib0004","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1007\/s12223-021-00918-5","article-title":"Ceftazidime-avibactam: are we safe from class A carbapenemase producers\u2019 infections?","volume":"66","author":"Moreira","year":"2021","journal-title":"Folia Microbiol."},{"key":"10.1016\/j.diagmicrobio.2025.116965_bib0005","series-title":"WHO bacterial priority pathogens list 2024 bacterial pathogens of public health importance, to guide research, development, and strategies to prevent and control antimicrobial resistance","year":"2024"},{"key":"10.1016\/j.diagmicrobio.2025.116965_bib0006","unstructured":"Food and Drug Administration [Internet]. [citado 14 de setembro de 2024]. Dispon\u00edvel em: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2015\/206494Orig1s000MicroR.pdf."},{"issue":"4","key":"10.1016\/j.diagmicrobio.2025.116965_bib0007","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.bjid.2020.05.010","article-title":"Activity of ceftolozane-tazobactam and comparators against gram-negative bacilli: results from the study for monitoring antimicrobial resistance trends (SMART \u2013 Brazil; 2016\u20132017)","volume":"24","author":"Beir\u00e3o","year":"2020","journal-title":"Braz J Infect Dis"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2025.116965_bib0008","doi-asserted-by":"crossref","DOI":"10.1128\/msphere.00651-22","article-title":"Molecular mechanisms of resistance to ceftazidime\/avibactam in clinical isolates of enterobacterales and Pseudomonas aeruginosa in Latin American Hospitals. Bradford PA, organizador","volume":"8","author":"Mojica","year":"2023","journal-title":"mSphere"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2025.116965_bib0009","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13756-021-00931-w","article-title":"Surveillance of antimicrobial resistance in low- and middle-income countries: a scattered picture","volume":"10","author":"Iskandar","year":"2021","journal-title":"Antimicrob Resist Infect Control."},{"issue":"11","key":"10.1016\/j.diagmicrobio.2025.116965_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3201\/eid2811.220415","article-title":"Increased detection of carbapenemase-producing enterobacterales bacteria in Latin America and the Caribbean during the COVID-19 pandemic","volume":"28","author":"Thomas","year":"2022","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2025.116965_bib0011","article-title":"ANVISA - National Health Surveillance Agency","year":"2018","journal-title":"National Health Surveillance Agency"},{"key":"10.1016\/j.diagmicrobio.2025.116965_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2023.106090","article-title":"Efficacy and safety of ceftazidime-avibactam compared to other antimicrobials for the treatment of infections caused by carbapenem-resistant Klebsiella pneumoniae strains, a systematic review and meta-analysis","volume":"179","author":"Karampatakis","year":"2023","journal-title":"Microb Pathog"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2025.116965_bib0013","first-page":"310","article-title":"Ceftazidime-avibactam susceptibility among KPC-producing enterobacterales in southern Brazil. Hcpa [Internet]","volume":"43","author":"Moreira","year":"2023","journal-title":"[citado 14 de setembro de 2024]"},{"key":"10.1016\/j.diagmicrobio.2025.116965_bib0014","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13756-025-01518-5","article-title":"Global trends of ceftazidime\u2013avibactam resistance in gram-negative bacteria: systematic review and meta-analysis","volume":"14","author":"Wang","year":"2025","journal-title":"Antimicrob Resist Infect Control"},{"issue":"Supplement_1","key":"10.1016\/j.diagmicrobio.2025.116965_bib0015","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1093\/cid\/ciad260","article-title":"A 7-year Brazilian national perspective on plasmid-mediated carbapenem resistance in enterobacterales, Pseudomonas aeruginosa, and Acinetobacter baumannii complex and the impact of the Coronavirus Disease 2019 pandemic on their occurrence","volume":"77","author":"Kiffer","year":"2023","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2025.116965_bib0016","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jgar.2024.06.007","article-title":"Susceptibility evaluation of novel beta-lactam\/beta-lactamase inhibitor combinations against carbapenem-resistant Klebsiella pneumoniae from bloodstream infections in hospitalized patients in Brazil","volume":"38","author":"Wilhelm","year":"2024","journal-title":"J Global Antimicrob Resist"},{"issue":"9","key":"10.1016\/j.diagmicrobio.2025.116965_bib0017","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00447-22","article-title":"Klebsiella pneumoniae carbapenemase variants resistant to ceftazidime-Avibactam: an evolutionary overview","volume":"66","author":"Hobson","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2025.116965_bib0018","doi-asserted-by":"crossref","DOI":"10.1128\/cmr.00008-23","article-title":"Klebsiella pneumoniae carbapenemase variants: the new threat to global public health. Bard JD, organizador","volume":"36","author":"Ding","year":"2023","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.diagmicrobio.2025.116965_bib0019","unstructured":"BrCAST."},{"issue":"4","key":"10.1016\/j.diagmicrobio.2025.116965_bib0020","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1093\/jac\/dkr563","article-title":"Rapid detection of carbapenemase genes by multiplex real-time PCR","volume":"67","author":"Monteiro","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2025.116965_bib0021","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jgar.2021.04.001","article-title":"Resistance to ceftazidime\/avibactam in infections and colonisations by KPC-producing enterobacterales: a systematic review of observational clinical studies","volume":"25","author":"Di Bella","year":"2021","journal-title":"J Global Antimicrob Resist"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2025.116965_bib0022","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02097-16","article-title":"Emergence of ceftazidime-avibactam resistance due to plasmid-borne bla KPC-3 mutations during treatment of carbapenem-resistant Klebsiella pneumoniae infections","volume":"61","author":"Shields","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"10.1016\/j.diagmicrobio.2025.116965_bib0023","doi-asserted-by":"crossref","first-page":"6605","DOI":"10.1128\/AAC.01165-15","article-title":"First report of ceftazidime-avibactam resistance in a KPC-3-expressing Klebsiella pneumoniae isolate","volume":"59","author":"Humphries","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2025.116965_bib0024","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01816-19","article-title":"Ceftazidime-avibactam resistance associated with increased bla KPC-3 gene copy number mediated by pKpQIL plasmid derivatives in sequence type 258 Klebsiella pneumoniae","volume":"64","author":"Coppi","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2025.116965_bib0025","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/s12866-021-02293-0","article-title":"Increased gene expression and copy number of mutated blaKPC lead to high-level ceftazidime\/avibactam resistance in Klebsiella pneumoniae","volume":"21","author":"Sun","year":"2021","journal-title":"BMC Microbiol"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2025.116965_bib0026","doi-asserted-by":"crossref","first-page":"lxae135","DOI":"10.1093\/jambio\/lxae135","article-title":"Whole genome sequencing analysis of seven unknown resistance mechanisms of carbapenem-resistant Klebsiella pneumoniae strains resistance to ceftazidime\u2013avibactam","volume":"135","author":"Chen","year":"2024","journal-title":"J Appl Microbiol"},{"key":"10.1016\/j.diagmicrobio.2025.116965_bib0027","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.2147\/IDR.S207993","article-title":"Molecular and phenotypical characterization of two cases of antibiotic-driven ceftazidime-avibactam resistance in blaKPC-3-harboring Klebsiella pneumoniae","volume":"12","author":"Venditti","year":"2019","journal-title":"IDR."},{"issue":"11","key":"10.1016\/j.diagmicrobio.2025.116965_bib0028","doi-asserted-by":"crossref","first-page":"5370","DOI":"10.1128\/AAC.05202-11","article-title":"Functional characterization of Tn4401, a Tn3-based transposon involved in blaKPC gene mobilization","volume":"55","author":"Cuzon","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2025.116965_bib0029","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.3389\/fmicb.2016.01000","article-title":"KPC-3-producing Klebsiella pneumoniae in Portugal linked to previously circulating Non-CG258 lineages and uncommon genetic platforms (Tn4401d-IncFIA and Tn4401d-IncN)","volume":"7","author":"Rodrigues","year":"2016","journal-title":"Front Microbiol"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889325002883?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889325002883?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T21:37:26Z","timestamp":1755553046000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889325002883"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S0732889325002883"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2025.116965","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"First report of ceftazidime-avibactam resistance in non-mutated blaKPC-3 K. pneumoniae recovered from patients with no prior treatment, in Latin America","name":"articletitle","label":"Article Title"},{"value":"Diagnostic Microbiology and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2025.116965","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116965"}}